Study on Shock Wave Therapy for Lateral Epicondylitis Shows Potential Benefits
A randomized controlled study is evaluating the efficacy of extracorporeal shock wave therapy on trigger points in lateral epicondylitis patients.
Phase III
Musculoskeletal / Lateral Epicondylitis
Status
Active
Signal Score
6.8
Signal assessment
Signal strength
moderate
Confidence level
moderate
Why it matters
The ongoing study on extracorporeal shock wave therapy for lateral epicondylitis could reshape treatment protocols and market dynamics in pain management. Positive outcomes may enhance the appeal of non-invasive therapies, prompting a shift in clinical practice and competitive positioning.
Recommended action
Humanexa recommends Monitor.
Analysis
Results on pain reduction and functional improvement at week 4 post-treatment.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.